Creatures

Cn /En

News Center

Company news

Industry news

InnoModels: Introducing the Advantages of the iHuPBMC-MHC/KO Platform

Author:

InnoModels

Release time:

2024-03-01

InnoModels Biotechnology has always been committed to providing the highest quality services and products for life science research. The company's iHuPBMC-MHC/KO platform, with many unique advantages, provides a powerful new tool for researchers in immunology and related fields.
First, iHuPBMC-MHC/KO provides a stable and homogeneous cell line that mimics the response of immune cells in humans. By employing knockout technology, this product is able to more accurately mimic the response of the human immune system to a variety of stimuli, which is extremely important for understanding the function of the immune system, the development of diseases, and the efficacy of drugs.

 


Secondly, iHuPBMC-MHC/KO cell lines present specific antigens on MHC-I and MHC-II-like molecules, which enables them to better mimic the response of T cells, an important component of the immune system, which play a crucial role in the fight against infection, tumors, and the regulation of autoimmune disease. Therefore, iHuPBMC-MHC/KO provides a more realistic model for T cell research.
In addition, iHuPBMC-MHC/KO has the advantage of being easy to culture and expand, which means that researchers can quickly obtain a sufficient number of cells for experiments. At the same time, due to its homogeneity, results between different experiments are more reproducible, which is essential for the rigor and reliability of scientific research.
Overall, with its unique advantages, iHuPBMC-MHC/KO from InnoModels Biotechnology provides a powerful new tool for research in immunology and related fields. It can help researchers gain a deeper understanding of the functioning mechanisms of the immune system and facilitate advances in disease treatment and drug development. In the future, with further research and application of iHuPBMC-MHC/KO, we have reason to believe that it will play a greater role in the field of life sciences.

Previous Page

InnoModels: iHuPBMC-B Platform Introduction

InnoModels: Introduction of iHuPBMC-NK Platform

Next Page

Previous Page

InnoModels: iHuPBMC-B Platform Introduction

Next Page

InnoModels: Introduction of iHuPBMC-NK Platform

InnoModels Biotechnology (Beijing) Co., Ltd.

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Powered by：CEglobal

Business License